Uncertainty confounds the patent landscape as Congress, the courts, industry, and patent practitioners attempt to manage major IP issues at a time when strong IP protection is critical and overall budgets are diminishing. There is no time more important than now to concentrate on fundamental IP strategy and how these policy issues will affect that strategy.
Join us for a Web conference providing insight from a leading corporate IP counsel, former top USPTO official, and practitioners to discuss:
- What does the future hold for patent reform legislation?
- How can new leadership impact the patent system?
- What are the outlook for and benefits of the reexamination practice?
- What will be the impact on patent litigation?
Speakers
David Kappos, Vice President and Assistant General Counsel, Intellectual Property Law and Strategy, IBM Corporation
Sharon Barner, Partner and Chair, IP Department, Foley
Jon Dudas, Partner, Foley, and former Under Secretary of Commerce for IP and Director, USPTO
Courtenay Brinckerhoff, Partner, Biotechnology & Pharmaceutical Practice, Foley
Foley will apply for CLE credit after the Web conference.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.